Real-time enrollment status for this metastatic castration-resistant prostate cancer (mcrpc) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:23 PM UTC
| NCT Number | NCT07570979 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| Phase | PHASE1 |
| Target Enrollment | 208 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of August 27, 2026: Clinical trial NCT07570979 is currently recruiting participants. This phase1 study for metastatic castration-resistant prostate cancer (mcrpc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07570979 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07570979 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.